Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide.
Recent studies have shown that n6-methyladenosine (m6A) plays a major role in …

N6-methyladenosine (m6A) is the most common and conserved internal eukaryotic mRNA
modification. m6A modification is a dynamic and reversible post-transcriptional regulatory …

Atherosclerosis (AS) is a life-threatening vascular disease. RNA N6-methyladenosine (m6A)
modification level is dysregulated in multiple pathophysiologic processes including AS. In …

Microglia-mediated inflammation is a major contributor to the brain damage in cerebral
ischemia and reperfusion (I/R) injury, and N6-Methyladenosine (m6A) has been implicated …

Epitranscriptomic modifications have recently emerged into the spotlight of researchers due
to their vast regulatory effects on gene expression and thereby cellular physiology and …

We performed a database mining on 102 transcriptomic datasets for the expressions of 29
m6A‐RNA methylation (epitranscriptomic) regulators (m6A‐RMRs) in 41 diseases and …

Purpose Atherosclerosis (AS) is a primary cause of cardiovascular diseases. This study
investigated the mechanism of methyltransferase-like 3 (METTL3) in AS plaques via …

Diabetes mellitus (DM) and its related complications are among the leading causes of
disability and mortality worldwide. Substantial studies have explored epigenetic regulation …

Objective Sudden cardiac death caused by ventricular arrhythmias (VAs) is the main cause
of high mortality in patients with myocardial infarction (MI). Sympathetic neural remodeling …

N-6-methyladenosine (m6A) is the most prevalent post-transcriptional RNA modification in
eukaryotic cells. The modification is reversible and can be dynamically regulated by writer …